Stay updated on ATH-1017 in Alzheimer's: Mild to Moderate Clinical Trial
Sign up to get notified when there's something new on the ATH-1017 in Alzheimer's: Mild to Moderate Clinical Trial page.

Latest updates to the ATH-1017 in Alzheimer's: Mild to Moderate Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe web page has been updated to version 2.15.0, replacing the previous version 2.14.4.SummaryDifference1.0%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.3%
- Check37 days agoChange DetectedThe page indicates that the ATH-1017-AD-0203 trial has been terminated due to not meeting its primary endpoint, and the results have been posted, reflecting a significant update in the trial's status.SummaryDifference4%
- Check52 days agoChange DetectedThe page now indicates that results have been submitted, replacing the previous message that no results were posted.SummaryDifference0.5%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
Stay in the know with updates to ATH-1017 in Alzheimer's: Mild to Moderate Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ATH-1017 in Alzheimer's: Mild to Moderate Clinical Trial page.